Diabetic nephropathy:: Of mice and men

被引:43
作者
Breyer, MD
Böttinger, E
Brosius, FC
Coffman, TM
Fogo, A
Harris, RC
Heilig, CW
Sharma, K
机构
[1] Vanderbilt Univ, Sch Med, Div Nephrol, Dept Med, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Sch Med, Div Nephrol, Dept Mol Physiol, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Sch Med, Div Nephrol, Dept Biophys, Nashville, TN 37232 USA
[4] VA Med Ctr Nashville, Nashville, TN 37232 USA
[5] CUNY Mt Sinai Sch Med, New York, NY 10029 USA
[6] Univ Michigan, Ann Arbor, MI 48109 USA
[7] Duke Univ, Durham, NC USA
[8] Durham VA Med Ctr, Durham, NC USA
[9] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[10] Thomas Jefferson Univ, Dorrance Hamilton Res Labs, Philadelphia, PA 19107 USA
关键词
streptozotocin; albuminuria; glomerular filtration; rate; inbred mice;
D O I
10.1053/j.ackd.2005.01.004
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Accumulating evidence supports intrinsic genetic susceptibility as an important variable in the progression of diabetic nephropathy in people. Mice provide an experimental platform of unparalleled power for dissecting the genetics of mammalian diseases; however, phenotypic analysis of diabetic mice lags behind that already established for humans. Standardized benchmarks of hyperglycemia, albuminuria, and measurements of renal failure remain to be developed for different inbred strains of mice. The most glaring deficiency has been the lack of a diabetic mouse model that develops progressively worsening renal insufficiency, the sine qua non of diabetic nephropathy in humans. Differences in susceptibility of these inbred strains to complications of diabetes mellitus provide a possible avenue to dissect the genetic basis of diabetic nephropathy; however, the identification of those strains and/or mutants most susceptible to renal injury from diabetes mellitus is lacking. Identification of a mouse model that faithfully mirrors the pathogenesis of DN in humans will undoubtedly facilitate the development of new diagnostic and therapeutic interventions. (c) 2005 by the National Kidney Foundation, Inc.
引用
收藏
页码:128 / 145
页数:18
相关论文
共 223 条
[1]   NONOBESE DIABETIC AND NONOBESE NONDIABETIC MICE HAVE UNIQUE MHC CLASS-II HAPLOTYPES [J].
ACHAORBEA, H ;
SCARPELLINO, L .
IMMUNOGENETICS, 1991, 34 (01) :57-59
[2]   DIABETIC GLOMERULONEPHROPATHY - HISTOPATHOLOGIC, IMMUNOFLUORESCENT, AND ULTRASTRUCTURAL STUDIES OF 16 CASES [J].
AINSWORTH, SK ;
HIRSCH, HZ ;
BRACKETT, NC ;
BRISSIE, RM ;
WILLIAMS, AV ;
HENNIGAR, GR .
HUMAN PATHOLOGY, 1982, 13 (05) :470-478
[3]   Use of genetic mouse models in the study of diabetic nephropathy [J].
Allen T.J. ;
Cooper M.E. ;
Lan H.Y. .
Current Atherosclerosis Reports, 2004, 6 (3) :197-202
[4]  
[Anonymous], 2003, Am J Kidney Dis, V42, P1
[5]   Improved diabetic syndrome in C57BL/KsJ-db/db mice by oral administration of the Na+-glucose cotransporter inhibitor T-1095 [J].
Arakawa, K ;
Ishihara, T ;
Oku, A ;
Nawano, M ;
Ueta, K ;
Kitamura, K ;
Matsumoto, M ;
Saito, A .
BRITISH JOURNAL OF PHARMACOLOGY, 2001, 132 (02) :578-586
[6]   APOE polymorphism and the progression of diabetic nephropathy in Japanese subjects with type 2 diabetes -: Results of a prospective observational follow-up study [J].
Araki, SI ;
Koya, D ;
Makiishi, T ;
Sugimoto, T ;
Isono, M ;
Kikkawa, R ;
Kashiwagi, A ;
Haneda, M .
DIABETES CARE, 2003, 26 (08) :2416-2420
[7]   Evidence for a familial pregnancy-induced hypertension locus in the eNOS-gene region [J].
Arngrimsson, R ;
Hayward, C ;
Nadaud, S ;
Baldursdottir, A ;
Walker, JJ ;
Liston, WA ;
Bjarnadottir, RI ;
Brock, DJH ;
Geirsson, RT ;
Connor, JM ;
Soubrier, F .
AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (02) :354-362
[8]   Endothelial nitric oxide synthase intron 4 polymorphism influences the progression of renal disease [J].
Asakimori, Y ;
Yorioka, N ;
Yamamoto, I ;
Okumoto, S ;
Doi, S ;
Hirai, T ;
Taniguchi, Y .
NEPHRON, 2001, 89 (02) :219-223
[9]   The NOD mouse model of type 1 diabetes: As good as it gets? [J].
Atkinson, MA ;
Leiter, EH .
NATURE MEDICINE, 1999, 5 (06) :601-604
[10]   The lack of cyclin kinase inhibitor p27Kip1 ameliorates progression of diabetic nephropathy [J].
Awazu, M ;
Omori, S ;
Ishikura, K ;
Hida, M ;
Fujita, H .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (03) :699-708